SCHEMBL8937688

SCHEMBL8937688

COc1ccc(/C(=C\C(=O)N2CCNCC2)c2ccccc2Cl)cc1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.52
RXFP1 Q9HBX9 1/20 0.52
ALDH1A1 P00352 3/20 0.46
MAPT P10636 2/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
POLB P06746 2/20 0.46
GPR183 P32249 3/20 0.43
ABL1 P00519 1/20 0.42
BCR P11274 1/20 0.42
MAOB P27338 1/20 0.42
MGLL Q99685 1/20 0.41
KDM4E B2RXH2 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8937691 1.00 KMT2A (0.52) KMT2ARXFP1ALDH1A1MAPTNPC1
SCHEMBL8937695 1.00 KMT2A (0.52) KMT2ARXFP1ALDH1A1MAPTNPC1
SCHEMBL8937490 0.85 GPR183 (0.52) ALDH1A1NPC1RAB9APOLBGPR183
SCHEMBL8937312 0.81 GPR183 (0.44) KMT2AALDH1A1MAPTNPC1RAB9A
SCHEMBL8937307 0.81 GPR183 (0.44) KMT2AALDH1A1MAPTNPC1RAB9A
SCHEMBL8937304 0.81 GPR183 (0.44) KMT2AALDH1A1MAPTNPC1RAB9A
SCHEMBL8937500 0.80 ALDH1A1 (0.64) KMT2AALDH1A1POLBGPR183ABL1
SCHEMBL8937637 0.80 ALDH1A1 (0.64) KMT2AALDH1A1POLBGPR183ABL1
SCHEMBL8937498 0.80 ALDH1A1 (0.64) KMT2AALDH1A1POLBGPR183ABL1
SCHEMBL8937669 0.80 ALDH1A1 (0.52) KMT2AALDH1A1MAPTGPR183ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5559109-A Method of treating a PAF-mediated pathology or for treating or preventing psoriasis, nephritis, asthma or shock by administering a PAF antagonist SANKKO COMPANY, LIMITED (JP) 1996-09-24 US disclosed
US-5556852-A PLATELET ACTIVATING FACTOR ANTAGONISTS SANKYO COMPANY, LIMITED (JP) 1996-09-17 US disclosed
US-5369106-A N-acryloylpiperazine derivatives, their preparation and their use of PAF antagonists SANKYO COMPANY, LIMITED (JP) 1994-11-29 US disclosed
US-5192766-A Platelet activating factor antagonist SANKYO COMPANY, LIMITED (JP) 1993-03-09 US disclosed